{"DataElement":{"publicId":"6825736","version":"1","preferredName":"Sinusoidal obstruction syndrome Outcome Type","preferredDefinition":"The response to a question asking about the SOS outcome for a patient.","longName":"SOS_OUTC_TP","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"6825734","version":"1","preferredName":"Sinusoidal obstruction syndrome Outcome","preferredDefinition":"A disorder characterized by severe hepatic injury as a result of the blood vessels of the liver becoming inflamed and/or blocked._The result of an action.","longName":"6769887v1.0:2224045v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6769887","version":"1","preferredName":"Sinusoidal obstruction syndrome","preferredDefinition":"A disorder characterized by severe hepatic injury as a result of the blood vessels of the liver becoming inflamed and/or blocked.","longName":"C143205","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sinusoidal Obstruction Syndrome, CTCAE","conceptCode":"C143205","definition":"A disorder characterized by severe hepatic injury as a result of the blood vessels of the liver becoming inflamed and/or blocked.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"CTCAE","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89A62005-A298-09EC-E053-F662850A222D","latestVersionIndicator":"Yes","beginDate":"2019-05-24","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-24","modifiedBy":"ONEDATA","dateModified":"2019-05-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2224045","version":"1","preferredName":"Outcome","preferredDefinition":"A phenomenon that follows and is caused by some previous phenomenon.","longName":"C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63F061C-D115-4EFF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-03","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-05-03","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E754265-E9AB-3CAF-E053-F662850AAB0D","latestVersionIndicator":"Yes","beginDate":"2019-07-24","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-07-24","modifiedBy":"SETRAKIN","dateModified":"2019-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6825735","version":"1","preferredName":"Outcome Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6825735v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Death due to other cause","valueDescription":"Death due to other cause","ValueMeaning":{"publicId":"5577904","version":"1","preferredName":"Death due to other cause","longName":"5577904v1.00","preferredDefinition":"Different than the one(s) previously specified or mentioned._The circumstance or condition that results in the death of a living being.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cause of Death","conceptCode":"C81239","definition":"The circumstance or condition that results in the death of a living being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4171F6EF-17F4-6D8D-E053-F662850A0A61","latestVersionIndicator":"Yes","beginDate":"2016-11-16","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-11-16","modifiedBy":"KUMMEROA","dateModified":"2022-08-01","changeDescription":null,"administrativeNotes":"2022.8.1 Added VM alt name. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E75C10F-3064-3C67-E053-F662850A0D7D","beginDate":"2019-07-24","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-07-24","modifiedBy":"ONEDATA","dateModified":"2019-07-24","deletedIndicator":"No"},{"value":"Death due to SOS","valueDescription":"Death due to SOS","ValueMeaning":{"publicId":"6144269","version":"1","preferredName":"Death due to SOS","longName":"6144269v1.00","preferredDefinition":"A disorder characterized by inflammation and damage of the hepatic sinusoidal endothelial cells of the hepatic venules that leads to venular occlusion and hepatocellular necrosis. It is most often a conditioning-related toxicity that results as a complication of hematopoietic stem cell transplantation (HSCT). It has also been described in populations of individuals who have ingested pyrrolizidine plant alkaloids. The clinical signs and symptoms include hyperbilirubinemia, hepatomegaly, and fluid retention._The circumstance or condition that results in the death of a living being.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sinusoidal Obstruction Syndrome","conceptCode":"C26793","definition":"A disorder characterized by inflammation and damage of the hepatic sinusoidal endothelial cells of the hepatic venules that leads to venular occlusion and hepatocellular necrosis. It is most often a conditioning-related toxicity that results as a complication of hematopoietic stem cell transplantation (HSCT). It has also been described in populations of individuals who have ingested pyrrolizidine plant alkaloids. The clinical signs and symptoms include hyperbilirubinemia, hepatomegaly, and fluid retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cause of Death","conceptCode":"C81239","definition":"The circumstance or condition that results in the death of a living being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67DEC808-0648-4A8F-E053-F662850A9976","latestVersionIndicator":"Yes","beginDate":"2018-03-20","endDate":null,"createdBy":"LEEW","dateCreated":"2018-03-20","modifiedBy":"KUMMEROA","dateModified":"2022-08-01","changeDescription":null,"administrativeNotes":"2022.8.1 Added VM alt name and concepts to make compliant. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E75C10F-306E-3C67-E053-F662850A0D7D","beginDate":"2019-07-24","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-07-24","modifiedBy":"ONEDATA","dateModified":"2019-07-24","deletedIndicator":"No"},{"value":"Resolved","valueDescription":"Resolution","ValueMeaning":{"publicId":"6063614","version":"1","preferredName":"Resolution","longName":"6063614","preferredDefinition":"A means of finding a solution to a problem, or a means of finding agreement or harmony.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Resolution","conceptCode":"C75906","definition":"A means of finding a solution to a problem, or a means of finding agreement or harmony.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A7E08E-26C5-4AA4-E053-F662850AD065","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GDEEN","dateModified":"2023-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E75C10F-3079-3C67-E053-F662850A0D7D","beginDate":"2019-07-24","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-07-24","modifiedBy":"ONEDATA","dateModified":"2019-07-24","deletedIndicator":"No"},{"value":"Ongoing","valueDescription":"Continue","ValueMeaning":{"publicId":"5664916","version":"1","preferredName":"Continue","longName":"5664916","preferredDefinition":"Remain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Continue","conceptCode":"C53279","definition":"Remain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"48925D0C-7EEF-2D01-E053-F662850AE02B","latestVersionIndicator":"Yes","beginDate":"2017-02-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E75C10F-3085-3C67-E053-F662850A0D7D","beginDate":"2019-07-24","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-07-24","modifiedBy":"ONEDATA","dateModified":"2019-07-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E75C10F-304D-3C67-E053-F662850A0D7D","latestVersionIndicator":"Yes","beginDate":"2019-07-24","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-07-24","modifiedBy":"SETRAKIN","dateModified":"2019-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"SOS Outcome:","type":"Preferred Question Text","description":"SOS Outcome:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E754265-E9C1-3CAF-E053-F662850AAB0D","latestVersionIndicator":"Yes","beginDate":"2019-07-24","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-07-24","modifiedBy":"SETRAKIN","dateModified":"2019-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}